Absent mitigation, higher US tariffs will slow 2025 growth to mid to high single digits and pressure gross margin; disciplined price mix, local finishing, and launch focus can preserve EBIT and sustain Puig's share and brand equity in prestige beauty.
Puig posted 8% constant-currency growth in Q2 to 1.09b euros, inline with consensus and mirroring Q1 momentum, while signaling a slowdown to 6-8% growth in 2025 after 11% in 2024. The pivot reflects anticipated higher US tariffs and broader category normalization, putting a premium on pricing, mix, and supply-chain localization to defend margins and sustain share.
Next 30-90 days focus on US pricing scenarios, retailer sell-in alignment for H2 launches, and investor messaging to reset expectations for 2025 normalization. Lock in promotional guardrails with Sephora and Ulta to protect mix, and pre-position inventory ahead of any tariff effective dates to avoid rush costs.
Luxury beauty growth is normalizing after two years of outperformance; fragrance remains resilient but faces tougher comps. China demand is uneven, with makeup and niche fragrance adoption offsetting macro caution, while the US is stable but more promotion sensitive. Competitors with US manufacturing capacity hold a cost advantage under tariff scenarios; Puig's brand equity and hero franchises provide pricing power, but success will hinge on agile supply-chain design and disciplined channel management.